skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hello,

Given the current price levels of both MRNA and PFE would this be a good time to take position in either one of those? If so which one would you recommend.

Thank you!
Read Answer Asked by Irek on February 14, 2025
Q: I would like to increase my investments in foreign, but non-USA situs, companies, by buying ADRs (as my estate would be subject to US estate taxes). Currently, I have smallish positions in NVO (NovoNordisk; Danish) and ALC (Alcon; Swiss), which I am planning to add to. However, I would like to invest in up to three additional ADRs. My approach to investing (over the past 3 decades) is very long term buy & hold (indefinite holds, to bequeath to future generations), so I am aiming for high-quality companies. Can you perhaps provide your thoughts on NVO and ALC, as well as suggest up to 5 additional ADRs for consideration? (I'm not a fan of tobacco or gaming stocks, but generally open to wide spectrum of ideas.)

Ted
Read Answer Asked by Ted on February 03, 2025
Q: I am underwater significantly (-20 %to 30%) on the above 5 companies. I have a well balanced portfolio so am looking to either sell the above and replace them or add to them. Can you please give me your thoughts on which ones you would ditch and which ones (if any) you would add to. If you have any suggestions as replacements for any that you consider should be sold I would appreciate it. Thanks for your ongoing great insights. Peter
Read Answer Asked by Peter on February 03, 2025
Q: Hi 5i, can you give me the names of 4 or 5 large cap pharmaceutical companies that are buyable now. Also I'm looking for 4 or 5 Biotech companies with one drug in the market making money and maybe something in the pipeline that looks like it has a good future? for example TGTX.
Read Answer Asked by Mark on January 09, 2025
Q: I have 2 Stocks in my Portfolio both of which have taken large hits recently resulting in sizeable pullbacks.

Both of these companies seemed to previously be doing well.

Would u say these stocks developed valuation issues or there was a material change in their fortunes currently or perceived going forward?

Would u hold, Buy more or sell these stocks at this point?
Read Answer Asked by Craig on January 07, 2025
Q: I've owned IQLT for a few years now. I've noticed that the VEA top holdings are quite similar to IQLT, but at a significantly reduced MER. Is it really worth paying that much more to continue to hold IQLT? Maybe you have better insight on the differences between the two than I do (?)
Read Answer Asked by James on January 03, 2025
Q: Happy holidays…. Tax loss selling….. proxy for TLT, VDE, EMXC, OXY, PICK, LLY, NXT, ZBH, AMD, -Thanks
Read Answer Asked by James on December 22, 2024
Q: Hi 5i
NVO sp is currently down 21 % on negative news of clinical trials on new weight loss drug...Expected weight loss from clinical trial was 25% and drug delivered only 22.7%...
How do you view the market reaction and where do you think sp goes from here...would 5i Take any action on this news?

How would 5i expect these results to affect HIMS going forward and would 5i be interested in starting small position in HIMS...if so, at what price would you consider reasonable.
thx
Read Answer Asked by jim on December 20, 2024
Q: BEI.UN,BCE,BYD,CAR.UN,CVO.CRR.UN.IMO.IFP.LNR.MEG.TECK.B.TD.TOU. .CVS,CRBD.CUS.AMD.NVO.CRBP.UBER.
Which stocks do you recommend selling and which to keep?
Read Answer Asked by Nizar on December 17, 2024
Q: Forward metrics for LLY and NVO show roughly the same revenue growth, but LLY shows much better earnings and ROE growth. What, then, is the case for recommending both (other than that the market is big enough for both to appreciate)? I realize that, for drug developers, depth of pipeline and patent expiry are also factors, but for simplicity have assumed that, in these respects, their situations and risks are comparable - in which case, shouldn't things like ROE growth turn out to be decisive?
Read Answer Asked by John on December 02, 2024
Q: Hi 5i Team.

I have some names in my TFSA account such as ATD, ATX and ENGH (and maybe some others) that are laggers and would like to move out of them and into something with potentially higher returns.
I also own the other names mentioned above.
What are your thoughts and could you recommend 3 to 5 Canadian and/or US names with the reasons and entry points.
also own NVDA that has grown to a huge percentage of the account.
I know that I should sell some but it has been such a great performer.


Thank you
Joe
Read Answer Asked by Joe on November 28, 2024
Q: I own the following in the health care field. Are there any other suggestions? My first choice is an ETF. I am considering IHI.

XLV, Stryker, JNJ, P & G

Thank you

Paul
Read Answer Asked by paul on November 21, 2024
Q: Hello

What is 5is shortlist preferences for these 3 sectors: Materials, Consumer Defensive & Healthcare.
* 3 USA & 3 CDA choices per would be a great starting point
Read Answer Asked by Brant on November 14, 2024
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!